Last updated on July 2020

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa


Brief description of study

The purpose of the study is to evaluate the efficacy and safety of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)

Clinical Study Identifier: NCT04242446

Find a site near you

Start Over

Hs0003 50161

Los Angeles, CA United States
  Connect »

Hs0003 05141

Tampa, FL United States
  Connect »

Hs0003 50137

East Windsor, NJ United States
  Connect »

Hs0003 50176

Fremont, CA United States
  Connect »

Hs0003 50141

Tampa, FL United States
  Connect »

HS0003

Columbus, OH United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.